RECRUITING

Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors

Talk to us

Conditions

Tumors

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To learn about the symptoms and changes our patients experience while receiving treatment for sinonasal or nasopharyngeal cancer

Official Title

Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors

Quick Facts

Study Start:2018-12-20
Study Completion:2029-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05733091

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Previously untreated patients with or suspected to have sinonasal malignancy or nasopharyngeal malignancy diagnosis based on either outside pathology report or MD Anderson pathology report.
  2. 2. Age ≥ 18 years
  3. 3. Plan to obtain the majority of treatment at MDACC including surgery and radiotherapy
  4. 4. Ability to understand and willingness to sign written informed consent
  1. 1. History of the previous solid or liquid malignancies, apart from skin cancers treated with local therapy.
  2. 2. Existing neurocognitive impairment that is not the result of sinonasal and nasopharyngeal cancers or is treatment.
  3. 3. Previous treatment for sinonasal or nasopharyngeal carcinomas, apart from biopsy.

Contacts and Locations

Study Contact

Shirley Su, MBBS
CONTACT
(713) 792-4720
sysu@mdanderson.org

Principal Investigator

Shirley Su, MBBS
PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center

Study Locations (Sites)

M D Anderson Cancer Center
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: M.D. Anderson Cancer Center

  • Shirley Su, MBBS, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2018-12-20
Study Completion Date2029-12-31

Study Record Updates

Study Start Date2018-12-20
Study Completion Date2029-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Tumors